Infectious Disease
MIS-C cases increased last fall, study finds
March 15, 2024
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
” data-action=subscribe>
Subscribe
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].
Back to Healio
Key takeaways:
- Cases of multisystem inflammatory syndrome in children increased last fall.
- Most MIS-C cases occur among children who have not been vaccinated against COVID-19.
Cases of multisystem inflammatory syndrome in children increased by nearly two-thirds last fall, aligning with an increase in COVID-19 activity, according to a study published in MMWR.
The study found that most cases of multisystem inflammatory syndrome in children (MIS-C) occur in children who are not vaccinated against COVID-19.
Data derived from Yousaf AR, et al. MMWR Morb Mortal Wkly Rep. 2024;doi:10.15585/mmwr.mm7310a2.
In 2020, the CDC published an updated definition of MIS-C, which took effect on Jan. 1, 2023. It replaced a definition from 2020 that required “the presence of fever, systemic inflammation using a number of biomarkers, and involvement of at least two of seven organ systems,” the authors of the new study wrote.
The new case definition no longer requires a duration of subjective or measured fever but does require a C-reactive protein (CRP) test result of 3 mg/dL or more to indicate systemic inflammation, among other changes, the authors noted, adding that 87% of cases reported using the 2020 case definition also meet the 2023 case definition.
As of Feb. 26, 2024, there were 117 new cases of MIS-C identified in 2023. Of these patients, 31 experienced onset of the syndrome from August through October, following an increase in COVID-19 activity earlier in the summer — a 63% increase in cases compared with the previous 3 months.
Overall, however, cases of MIS-C have decreased 98% from a peak during October 2020 to April 2021, according to the authors.
Among the 117 MIS-C cases identified in 2023, 58% occurred in previously healthy children with no underlying medical conditions, 50% required ICU-level care, 34% experienced shock and 27% experienced cardiac dysfunction, the researchers found. Three of the children died.
Additionally, although 96% of the patients with MIS-C were eligible for COVID-19 vaccination, only 18% had any documented evidence of being vaccinated. Among the 20 vaccinated children, 12 had received their last dose over 12 months before onset of MIS-C.
Among all 117 patients, 27.4% had obesity, 13.7% had a chronic lung disease such as asthma, 7.7% had a developmental condition, 5.1% had a cardiovascular condition and 1.7% had an immunosuppressive disorder or malignancy.
The authors reiterated the CDC’s recommendation that all eligible children remain up to date with COVID-19 vaccination.
“MIS-C patients with illness onset in 2023 were predominantly unvaccinated children and those whose vaccine-induced immunity had likely waned,” they wrote. “COVID-19 vaccination remains an important tool for preventing MIS-C.”
Published by:
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
” data-action=subscribe>
Subscribe
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].
Back to Healio